- Details
- Description
Ventoxen (Venetoclax INN 100 mg) is an oral oncology medicine manufactured by Everest Pharmaceuticals Ltd., Bangladesh. It contains Venetoclax 100 mg, a selective BCL-2 inhibitor that helps restore programmed cell death (apoptosis) in certain cancer cells. Venetoclax is used in the treatment of specific hematological malignancies, including certain forms of chronic lymphocytic leukemia (CLL) and acute myeloid leukemia (AML), according to the approved indication and treatment protocol. Everest’s prescribing information states that each film-coated tablet contains Venetoclax INN 100 mg, and the product is supplied in an HDPE container containing 60 tablets.
